Evaluation of a new ultralow-dose radiation protocol for electrophysiological device implantation: A near-zero fluoroscopy approach for device implantation

Radiation is one of the main hazards of electrophysiological device implantation, and insertion of cardiac resynchronization therapy (CRT) devices in particular is associated with high radiation doses.
Source: Heart Rhythm - Category: Cardiology Authors: Source Type: research

Related Links:

A 59-year-old woman with a history of non-ischemic cardiomyopathy (ejection fraction of 30%) and obesity was admitted to internal medicine with palpitations. She had undergone uncomplicated cardiac resynchronization therapy with defibrillator (CRT-D) placement five days previously. At a skilled nursing facility, she experienced an intermittent pulsating feeling in her left chest several times per day. She described the feeling as the sensation of “somebody doing CPR from the inside.” She was referred to the emergency department for further evaluation.
Source: The American Journal of Medicine - Category: General Medicine Authors: Tags: Clinical Communication to the Editor Source Type: research
ConclusionsThe total consumption of pacemaker generators in Spain increased by 1.2% compared with 2017, mainly due to an 8.7% increase in cardiac resynchronization therapy with pacemaker generators. Selection of pacing mode was directly influenced by age and sex.ResumenIntroducción y objetivosSe describe el resultado del análisis de los dispositivos de estimulación implantados y remitidos al Registro Español de Marcapasos en 2018.MétodosInformación que aporta la Tarjeta Europea del Paciente Portador de Marcapasos, así como los datos proporcionados por la industria sobre el n...
Source: Revista Espanola de Cardiologia - Category: Cardiology Source Type: research
Heart failure (HF) is a complicated syndrome, and despite advances in medical and device-based therapies in the last three decades, the 5-year mortality of patients with HF remains around 50%.1 Increasingly, patients with HF are implanted with implantable cardioverter defibrillators or cardiac resynchronization therapy devices that possess the capability of measuring many diagnostic parameters.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Source Type: research
An implantable neuromodulation device was approved for symptom improvement in patients with advanced heart failure who aren ’t eligible for cardiac resynchronization therapy. Heart failure is the fourth leading cause of death attributable to cardiovascular disease, affecting 5.7 million people in the United States.
Source: JAMA - Category: General Medicine Source Type: research
Nearly one-third of heart failure (HF) patients do not respond to cardiac resynchronization therapy (CRT) despite having left bundle branch block (LBBB). The aim of the study was to investigate a novel method ...
Source: Cardiovascular Ultrasound - Category: Radiology Authors: Tags: Research Source Type: research
Condition:   Cardiac Resynchronization Therapy, Non-LBBB, QRS Area Intervention:   Device: Cardiac resynchronization therapy Sponsors:   Maastricht University Medical Center;   Medtronic Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
This article provides a review of the aforementioned mechanisms of arrhythmogenesi s in heart failure; the role and impact of HF therapy such as cardiac resynchronization therapy (CRT), including the role, if any, of CRT-P and CRT-D in preventing VAs; the utility of both non-invasive parameters as well as multiple implant-based parameters for telemonitoring in HF; and the effect o f left ventricular assist device implantation on VAs.
Source: Journal of Interventional Cardiac Electrophysiology - Category: Cardiology Source Type: research
We report the outcome and safety of transvenous excimer laser-assisted lead extraction of CIEDs in Japanese patients aged ≥80 years. METHODS: Consecutive 235 patients (age 67±15 years, 167 male) undergoing lead extraction of CIED with an excimer laser system (Philips, Andover, MA, USA) were included. RESULTS: Of 235 consecutive patients, 51 (22%) were ≥80 years (age 86±5 years, 14 were aged ≥90 years; 42 had pacemakers, 3 had implantable cardioverter defibrillators, and 6 had cardiac resynchronization therapy devices). The median implant duration was 110±95 months. Patients aged ≥...
Source: Journal of Cardiology - Category: Cardiology Authors: Tags: J Cardiol Source Type: research
More News: Cardiac Resynchronization Therapy | Cardiology | Heart